Current COPD and Asthma guidance is not in favour of using LABA on its own.
LABAs should be taken only in combination with a corticosteroid to treat asthma.
In COPD LABAs should be offered in a combination with LAMA if there are no
asthmatic features/features suggesting steroid responsiveness or considered in combination with ICS if there are asthmatic features/features
suggesting steroid responsiveness.
For people using long-acting bronchodilators outside of above recommendations
before NICE guideline [NG115] was published (December 2018), explain to them
that they can continue with their current treatment until both they and their NHS healthcare professional agree it is appropriate to change.